Argent Biopharma (AU:RGT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent BioPharma Limited has requested a trading halt on its shares as it prepares to make an important announcement regarding a capital raising. The halt will remain in place until the announcement is released or normal trading resumes on January 7, 2025. Investors are eagerly awaiting further details as the company positions itself for potential growth.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.